Literature DB >> 8575280

Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study.

R S Cajulis1, G K Haines, D Frias-Hidvegi, K McVary, J W Bacus.   

Abstract

The diagnosis of transitional cell carcinoma (TCC) in bladder washes is a diagnostic challenge to cytology. This study assessed the role of flow cytometry (FCM), image analysis (IA), and interphase cytogenetics by fluorescence in situ hybridization (FISH) as adjuncts in the cytodiagnosis of TCC in bladder washes. Forty separate samples of bladder washes were prospectively evaluated by conventional cytology (CY), FCM, IA, and FISH, and the results were compared with the subsequent surgical biopsy specimens which revealed 26 TCC (3 GR I, 6 GR II, 17 GR III) and 14 benign lesions. Using histology as the "gold standard" and following the previously published criteria for detection of TCC by CY, FCM, IA, and FISH, the concordance rates between histology and CY, FCM, IA, and FISH were 75, 74, 89, and 83%, respectively. CY, FCM, IA, FISH, and histology were concordant in 54% of the cases. The sensitivity of CY, FCM, IA, and FISH were 61, 72, 91, and 73%, respectively, while the specificity were 100, 80, 83, and 100%, respectively. The combined sensitivity of all the parameters was 96%. Interestingly, the false positive cases by FCM and IA showed cystitis. We conclude that IA has the highest sensitivity in detecting TCC in bladder washes followed by FISH, FCM, and CY, while CY and FISH have the highest specificity. This study indicates that FCM, IA, and FISH are useful adjuncts to cytology in the diagnosis of TCC in bladder washes. The finding of DNA-aneuploidy in cystitis warrants further investigation.

Entities:  

Mesh:

Year:  1995        PMID: 8575280     DOI: 10.1002/dc.2840130307

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  14 in total

1.  Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.

Authors:  Hugang Ren; Wayne C Waltzer; Rahuldev Bhalla; Jingxuan Liu; Zhijia Yuan; Christopher S D Lee; Frank Darras; David Schulsinger; Howard L Adler; Jason Kim; Alek Mishail; Yingtian Pan
Journal:  Urology       Date:  2009-08-05       Impact factor: 2.649

2.  DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats.

Authors:  Paula A Oliveira; Filomena Adega; Carlos A Palmeira; Raquel M Chaves; Aura A Colaço; Henrique Guedes-Pinto; Luis F De la Cruz P; Carlos A Lopes
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

3.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

Authors:  I A Sokolova; K C Halling; R B Jenkins; H M Burkhardt; R G Meyer; S A Seelig; W King
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

4.  A pilot study of urinary microRNA as a biomarker for urothelial cancer.

Authors:  Jaime Snowdon; Sandy Boag; Harriet Feilotter; Jason Izard; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

5.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

6.  Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.

Authors:  Sahar M Hazzaa; Osama M Elashry; Ibtesam K Afifi
Journal:  Pathol Oncol Res       Date:  2009-09-09       Impact factor: 3.201

Review 7.  Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.

Authors:  Eric Schiffer; Harald Mischak; Dan Theodorescu; Antonia Vlahou
Journal:  World J Urol       Date:  2008-01-04       Impact factor: 4.226

Review 8.  Urinary proteomic profiling for diagnostic bladder cancer biomarkers.

Authors:  Steve Goodison; Charles J Rosser; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

9.  Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.

Authors:  Paweena Kreunin; Jia Zhao; Charles Rosser; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  J Proteome Res       Date:  2007-05-23       Impact factor: 4.466

10.  Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.

Authors:  Charles J Rosser; Li Liu; Yijun Sun; Patrick Villicana; Molly McCullers; Stacy Porvasnik; Paul R Young; Alexander S Parker; Steve Goodison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.